Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon



Rating:

Share or cite this content

Citations should be made in the following way:
V. Delmotte (Liège, Belgium). ANCA Associated Vasculitis in older patients. International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon

Member's Comments

No comment yet.

Related content which might interest you: ANCA associated vasculitis – Evaluation of diagnosis, treatment and outcome in a group of 68 patients Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis Year: 2014 Vasculitis Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Vasculitis Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Cure bronchiectasis associated with anti-neutrophil cytoplasmatic antibodies (ANCA) with immunosuppressive therapy Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020 Plasma derived-exosome microRNAs in Idiopathic Pulmonary Fibrosis of Anti-synthetase syndrome Disease patients Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Challenges in the management of patients with ANCA- associated vasculitides Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 Occurrence of ANCA positivity in persons with silicosis Source: Eur Respir J 2002; 20: Suppl. 38, 604s Year: 2002 Increased Severity of Asthma in Atopic Patients with Eosinophilic Granulomatosis with Polyangiitis Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Pattern of Periodontal diseases in Hospitalized Patients with Non-Tubercular Respiratory diseases Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019 Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): Clinical, serological and radiological heterogeneity Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 PES Pathogens in Elderly Patients with Acquired Pneumonia in the Community Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Prevalence of Pulmonary Embolism Among Systemic Lupus Erythematosus patients Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020 Antineutrophil cytoplasmic antibodies (ANCA) associated-bronchiectasis appears more severe than "idiopathic" bronchiectasis Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice Year: 2015 Anti-synthetase syndrome associated Interstitial Lung Disease (ASS-ILD): clinical heterogeneity and outcome Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Prevalence of Eosinophilia in Patients with Tuberculosis Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Ocular manifestations of sarcoidosis in Turkish patients Source: Eur Respir J 2003; 22: Suppl. 45, 440s Year: 2003 Microbiota in children with HIV-associated bronchiectasis Source: International Congress 2016 – Paediatric respiratory infection and immunology Year: 2016 Lung involvement in ANCA associated crescentic glomerulonephritis Source: Eur Respir J 2005; 26: Suppl. 49, 31s Year: 2005 Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020